Projects funded by the NCN

DNA repair pathways contributing to resistance to photodynamic therapy and as possible theraupeutic targets

Call: OPUS 8 , Panel: NZ5

Principal investigator: dr hab. Elżbieta Speina

Instytut Biochemii i Biofizyki PAN

Could fibroblast senescence and their resistance to apoptosis be the hidden drivers behind endometrial fibrosis in equin...

Call: OPUS 28 , Panel: NZ5

Principal investigator: dr Katarzyna Karolina Piotrowska-Tomala

Instytut Rozrodu Zwierząt i Badań Żywności PAN

Factors associated with a modulation of fibrin clot structure and resistance to fibrinolysis in patients with protein C ...

Call: OPUS 28 , Panel: NZ5

Principal investigator: dr hab. Michał Tomasz Ząbczyk

Krakowski Szpital Specjalistyczny im. Jana Pawła II

Extensive analysis of the immunological profile of pediatric patients with acute lymphoblastic leukemia in order to iden...

Call: PRELUDIUM 22 , Panel: NZ5

Principal investigator: Anna Krętowska-Grunwald

Uniwersytet Medyczny w Białymstoku

Role of the PARP1/HPF1 complex in the conferring of resistance to doxorubicin in triple negative breast cancer

Call: PRELUDIUM 21 , Panel: NZ5

Principal investigator: Magdalena Alicja Strachowska

Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

New strategy for overcoming resistance to chemotherapy of ovarian cancer by modulation of the canonical and non-canonica...

Call: OPUS 22 , Panel: NZ5

Principal investigator: dr hab. Radosław Januchowski

Uniwersytet Zielonogórski, Collegium Medicum

Inhibiting the Mitochondrial Intermembrane Space Assembly pathway as a newapproach to prevent metabolic reprogramming of...

Call: OPUS 22 , Panel: NZ5

Principal investigator: dr hab. Carlo Vascotto

Międzynarodowy Instytut Mechanizmów i Maszyn Molekularnych Polskiej Akademii Nauk

Phage treatment and wetland technology as intervention strategy to prevent dissemination of antibiotic resistance in sur...

Call: JPIAMR-ACTION Call 2021 , Panel: NZ9

Principal investigator: dr Małgorzata Dorota Grzesiuk-Bieniek

Szkoła Główna Gospodarstwa Wiejskiego w Warszawie, Instytut Biologii

Analysis of semaphorin 3 (SEMA3), protocadherin 9 (PCDH9) and S 100 calcium binding proteinA3 (S100A3) expression in pro...

Call: OPUS 21 , Panel: NZ5

Principal investigator: dr hab. Radosław Januchowski

Uniwersytet Zielonogórski, Collegium Medicum

Changes in lipid metabolism of resistant to BRAF/MEK inhibitors human melanoma cells associated with the presence of adi...

Call: SONATA 16 , Panel: NZ5

Principal investigator: dr Aleksandra Simiczyjew

Uniwersytet Wrocławski, Wydział Biotechnologii

Identifying and overcoming mechanisms promoting resistance to venetoclax in B cell acute lymphoblastic leukemia with MLL...

Call: PRELUDIUM 16 , Panel: NZ5

Principal investigator: dr Klaudyna Paulina Fidyt

Warszawski Uniwersytet Medyczny, Wydział Lekarski

The significance of cancer specific PFK-II (PFKFB3 and PFKFB4) isoenzymes inhibition in overcoming resistance to BRAF in...

Call: PRELUDIUM 16 , Panel: NZ5

Principal investigator: Sonia Elżbieta Trojan

Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum

Association of TXNDC5 and calreticulin with decreased ER stress, allowing resistant multiple myeloma cells to by-pass pr...

Call: PRELUDIUM 15 , Panel: NZ5

Principal investigator: Tadeusz Franciszek Kubicki

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Lekarski

Regulation of epithelial to mesenchymal transition and therapy resistance to antitumor therapies by MCPIP1

Call: SONATA BIS 7 , Panel: NZ5

Principal investigator: dr hab. Katarzyna Miękus

Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

Proteomic analysis of myeloma plasma cells to determine proteins and pathways involved in acquired resistance to proteas...

Call: OPUS 13 , Panel: NZ5

Principal investigator: dr Dominik Dytfeld

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Lekarski II

Zinc Deficiency: An essential Variable for the Induction od Resistance to Antidepressants

Call: PRELUDIUM 13 , Panel: NZ5

Principal investigator: dr Anna Maria Rafało-Ulińska

Instytut Farmakologii PAN

Evaluation of anticancer potential of glutamine metabolism modulation in multiple myeloma sensitive and resistant to che...

Call: PRELUDIUM 11 , Panel: NZ5

Principal investigator: Monika Katarzyna Prełowska

Uniwersytet Warszawski, Centrum Nowych Technologii Uniwersytetu Warszawskiego

Protein and gene expression analysis in the course of renal cancer stem-like cells' primary resistance to sorafenib in h...

Call: PRELUDIUM 9 , Panel: NZ5

Principal investigator: Zofia Felicja Bielecka

Wojskowy Instytut Medyczny